Newer biologic drugs can be used along with an inhaler to help control respiratory symptoms due to asthma and COPD. These medications include Dupixent (dupilumab), approved by the Food and Drug ...

According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...

The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as ...

Virginia Castellanos, a South Bay Union School District nurse, is at work when her phone buzzes. “It stinks really bad at ...

The Carroll County Board of Education is seeking feedback on its policy on student exclusion and physical restraint, and its ...

Doctors and patients should rigorously evaluate diagnosis and treatment compliance before turning to biologics, two ...

Respiratory tract diseases are illnesses that affect components of the respiratory system, including the nasal passages, the bronchi and the lungs. They range from acute infections, such as ...

These findings support a shift in mild asthma management toward as-needed anti-inflammatory reliever therapy rather than relying on bronchodilators alone, even in cases traditionally managed without ...

Adult asthma affects more than 25 million Americans, yet many sufferers unknowingly engage in daily practices that exacerbate ...

Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic obstructive pulmonary disease ...

On May 6, 2025, the Global Initiative For Asthma (GINA) published the 2025 update to their Global Strategy for Asthma ...

Region residents are no strangers to tricky weather, well-accustomed to everything from winter snowstorms and deep freezes to ...